BioLineRx (BLRX) Cash & Equivalents (2010 - 2026)
BioLineRx (BLRX) posted Cash & Equivalents of $4.63 million for the quarter ended Jun 30, 2026, down 35.6% from $7.19 million a year earlier but up 84.8% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Cash & Equivalents (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Cash & Equivalents came in at $3.25 million, down 68.9% from the prior year.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -28.0% (years ended Dec 2020 to Dec 2025).
- In prior years, BioLineRx's Cash & Equivalents was $10.44 million in the year ended Dec 31, 2024 (+145.3%), $4.26 million in the year ended Dec 31, 2023 (-59.8%), $10.59 million in the year ended Dec 31, 2022 (-18.5%) and $12.99 million in the year ended Dec 31, 2021 (-22.8%).
- Quarterly Cash & Equivalents has run from a low of $2.5 million in the quarter ended Mar 31, 2026 to a high of $14.08 million in the quarter ended Sep 30, 2021 over five years.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last five quarters, with an average decline of 0.3% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was the quarter ended Dec 31, 2024, with growth of 145.3%; the weakest was the quarter ended Mar 31, 2026, with a decline of 72.3%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $2.5 million (quarter ended Mar 31, 2026), $3.25 million (quarter ended Dec 31, 2025) and $7.91 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | 4.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.63 Mn |
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 3.25 Mn |
| Sep 30, 2025 | 7.91 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Mar 31, 2025 | 9.04 Mn |
| Dec 31, 2024 | 10.44 Mn |
| Sep 30, 2024 | 8.84 Mn |
| Jun 30, 2024 | 9.62 Mn |
| Mar 31, 2024 | 5.99 Mn |
| Dec 31, 2023 | 4.26 Mn |
| Sep 30, 2023 | 7.73 Mn |
| Jun 30, 2023 | 10.10 Mn |
| Mar 31, 2023 | 9.07 Mn |
| Dec 31, 2022 | 10.59 Mn |
| Sep 30, 2022 | 13.11 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Mar 31, 2022 | 11.45 Mn |
| Dec 31, 2021 | 12.99 Mn |
| Sep 30, 2021 | 14.08 Mn |
API Access
BioLineRx Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();